Login / Signup

Evaluation of serum interleukin-6 (IL-6), IL-13, and IL-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients.

Dilek TezcanAbdullah SivrikayaDilek ErgunHalil ÖzerDuygu Eryavuz OnmazMuslu Kazım KörezTuran AkdağSemral GülcemalMuhammet LimonSema Yilmaz
Published in: Clinical rheumatology (2021)
At the study, it has been observed that serum IL-13, IL-6 and IL-17 levels are increased in patients with CTD-ILD. Besides, IL-6 was associated with disease activity scores of DAS28, ESDAII, and dSSc. Also, HRCT fibrosis score is associated with dSSc. Further and comprehensive studies are needed to understand better the complex intersection of lung disease with systemic autoimmunity. Key Points • Serum IL-13, IL-6, and IL-17 levels are increased in patients with CTD-ILD. • IL-6 was associated with disease activity scores of DAS28, ESDAII, and diffuse skin involvement. • HRCT fibrosis score is associated with diffuse skin involvement in patients with SSc-ILD. • HRCT inflammation score is associated with PAH.
Keyphrases
  • disease activity
  • interstitial lung disease
  • rheumatoid arthritis
  • computed tomography
  • systemic lupus erythematosus
  • magnetic resonance imaging
  • rheumatoid arthritis patients
  • contrast enhanced
  • liver fibrosis